Back to search

National and Kapodistrian University of Athens

Επιλογή του καταλληλότερου δότη για μεταμόσχευση ομφαλοπλακουντιακού αίματος, με βάση τα μη κληρονομούμενα μητρικά αντιγόνα (Non Inherited Maternal Antigens, NIMA)

Abstract

dc:description

The number of unrelated allogeneic CB transplantations from HLA-compatible donors has significantly increased. The “collection” of HLA phenotypes at the HSC donor registries and CB Banks enables the preliminary investigations for patients, to be carried out through local National Transplant Organizations. Aiming to the easy disposition of the CBUs, CB Banks upload their cryostored CBUs in BMDW registry, sharing the basic data required for a preliminary search process. In the result of a search, the CBUs are sorted firstly by the level of HLA matching with the recipient and secondly by the cell content. Other parameters can also be used as result “filters”, in order to determine the most suitable HLA matched donor among a few pre-selected candidates. The BMDW registry includes 800.000 CBUs but nevertheless, when preparing a HSCT, it is not always possible to find a CB donor with full HLA matching with the patient-recipient. The post-transplant complications and GvHD remain significant obstacles in CB HSCT, especially for patients who have no other choice but receive HSC from a CB donor with mismatched HLA antigens. Because of the advantages of the CB HSCT, it has now become necessary to find an alternative strategy for the selection of a suitable CB donor for HSCT, that will focus on HLA matching between donor and recipient. A new arising strategy focuses on the selection of “acceptable” HLA mismatches which are associated with low grade immunogenicity, such as the NIMA of CB. After NIMA matching CB transplantation of patients with haematological malignancies, a lower TRM rate and faster transplant engraftment were observed and, therefore, a lower overall mortality rate compared to cases where there was no HLA matching between the recipient and the NIMA of the CBU. Considering the satisfactory results of NIMA matching CB transplantation, it is concluded that NIMA could be taken into account in the CBU selection procedure, provided that the neonatal donor maternal HLA antigens have been typed. While selecting the most appropriate CB donor for HSCT, it is possible that a CBU with NIMA matching with the recipient could prevail over a CBU with full HLA matching with him. Therefore, an alternative strategy is proposed for the CBU selection procedure, based on the identification of NIMA. In addition to the “improvement” of HLA matching between a potential HSC recipient and a seemingly HLA mismatched CBU, the NIMA-based methodology could contribute to the identification of a second, accompanying CBU for the potential recipient. In this way,a higher cell dose could be administered to the recipient, through a double CB transplantation, improving the chances of faster transplant engraftment and eliminating the chances for post-transplant complications. Using the NIMA-based methodology, the HCBB aims to establish a new policy for the search of HLA matched CBUs for patients, which is going to contributeto: a) the rapid identification of HLA matched CBUs for patients with no compatible CBU available and b) increasing the rate of CBU “release” from the cryostorage tanks, limiting the storage problem and the effect of the long storage on the cell viability of CBUs.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Panagouli, Effrosyni
  • Παναγούλη, Ευφροσύνη

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/46465

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Panagouli, Effrosyni; Παναγούλη, Ευφροσύνη. Επιλογή του καταλληλότερου δότη για μεταμόσχευση ομφαλοπλακουντιακού αίματος, με βάση τα μη κληρονομούμενα μητρικά αντιγόνα (Non Inherited Maternal Antigens, NIMA). National and Kapodistrian University of Athens, 2019. http://hdl.handle.net/10442/hedi/46465